Stockscreener 앱 받기
5.71
7.31%
-0.45
시간 외 거래:
5.71
전일 마감가:
$6.16
열려 있는:
$6.14
하루 거래량:
357.58K
Relative Volume:
2.19
시가총액:
$108.37M
수익:
$52.55M
순이익/손실:
$-23.69M
주가수익비율:
-6.0745
EPS:
-0.94
순현금흐름:
$-15.29M
1주 성능:
-5.15%
1개월 성능:
+29.77%
6개월 성능:
+100.35%
1년 성능:
+304.96%
1일 변동 폭
$5.51
$6.31
1주일 범위
$5.51
$7.20
52주 변동 폭
$1.38
$7.20
Exagen Inc Stock (XGN) Company Profile
명칭
Exagen Inc
전화
(760) 560-1501
주소
1261 LIBERTY WAY, VISTA, CA
XGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
5.71 | 108.37M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
403.13 | 159.89B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.73 | 142.45B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
491.70 | 37.95B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
106.93 | 30.97B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
148.99 | 26.72B | 15.50B | 1.33B | 2.16B | 7.34 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-08-05 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-04-15 | 개시 | Canaccord Genuity | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-08 | 개시 | BTIG Research | Buy |
| 2020-06-02 | 재개 | Cantor Fitzgerald | Overweight |
| 2019-10-14 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-10-14 | 개시 | Cowen | Outperform |
| 2019-10-14 | 개시 | William Blair | Outperform |
모두보기
Exagen Inc 주식(XGN)의 최신 뉴스
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter's Option to Purchase Additional Shares | XGN Stock News - GuruFocus
Exagen Inc. Announces Closing of $20.2 Million Public - GlobeNewswire
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares - Stock Titan
Earnings Update: Here's Why Analysts Just Lifted Their Exagen Inc. (NASDAQ:XGN) Price Target To US$7.75 - simplywall.st
Exagen Inc (XGN)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX
William Blair Issues Pessimistic Outlook for Exagen Earnings - Defense World
Exagen prices 3.35M shares at $5.25 per share in public offering - TipRanks
Exagen Prices $17.6 Million Public Offering; Shares Down - marketscreener.com
Exagen Inc. Prices Public Offering Of Common Stock At $5.25 Per Share - marketscreener.com
Exagen prices public offering of common stock - MSN
Exagen (XGN) Sets Price for Public Offering of Common Shares | XGN Stock News - GuruFocus
Exagen First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Exagen sets price for public stock offering at $5.25 per share - Investing.com Australia
Exagen Inc. Prices Public Offering of Common Stock | XGN Stock News - GuruFocus
Exagen Inc. Prices Public Offering of Common Stock - Bluefield Daily Telegraph
William Blair Estimates Exagen’s Q1 Earnings (NASDAQ:XGN) - Defense World
Exagen announces common stock offering, no amount given - TipRanks
Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates - MSN
Exagen Inc. anticipates $65M revenue for 2025 amid ASP growth and new biomarker launches - MSN
Exagen (XGN) Announces Public Offering of Common Stock | XGN Stock News - GuruFocus
Exagen Inc. Announces Proposed Public Offering of Common Stock - The Manila Times
Exagen (XGN) Sees Price Target Increase Following Strong Q1 Performance | XGN Stock News - GuruFocus
Marshall Wace LLP Acquires Shares of 16,048 Exagen Inc. (NASDAQ:XGN) - Defense World
KeyBanc maintains Exagen stock at Sector Weight By Investing.com - Investing.com Nigeria
KeyBanc maintains Exagen stock at Sector Weight - Investing.com
Exagen Inc (XGN) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic Wins Amidst ... - Yahoo Finance
Earnings call transcript: Exagen Inc. Q1 2025 revenue beats forecasts, stock dips - Investing.com Nigeria
Exagen Inc (XGN) Q1 2025 Earnings Call Highlights: Revenue Growt - GuruFocus
Exagen Inc. Reports Record Revenue Amid Strategic Growth - TipRanks
Exagen Inc. Earnings Call Highlights Record Growth - TipRanks
Exagen Inc (XGN) Q1 2025 Earnings: Revenue Surpasses Estimates a - GuruFocus
Exagen Inc reports results for the quarter ended March 31Earnings Summary - TradingView
EXAGEN INC. SEC 10-Q Report - TradingView
Exagen Inc (XGN) Q1 2025 Earnings: Revenue Surpasses Estimates at $15.5M, EPS Matches Expectations at -$0.20 - GuruFocus
Exagen Inc. Reports Record Q1 2025 Revenue Driven by Growth in Average Selling Price and Testing Volume | XGN Stock News - GuruFocus
XGN Projects Revenue Growth and Positive EBITDA by 2025 | XGN Stock News - GuruFocus
Exagen Inc. Reports Record Q1 2025 Revenue Driven by Growth in Average Selling Price and Testing Volume - The Manila Times
Exagen Inc. Reports Record Q1 2025 Revenue - TradingView
Exagen Q1 Earnings: Record $15.5M Revenue as New Lupus Test Launch Sparks Growth Path to Profitability - Stock Titan
Geode Capital Management LLC Grows Holdings in Exagen Inc. (NASDAQ:XGN) - Defense World
Exagen Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
Exagen Inc (XGN) Q1 2025 Earnings Report Preview: What To Expect - GuruFocus
Exagen announces senior secured credit facility - MSN
Exagen (XGN) Secures $75 Million Credit Facility to Enhance Fina - GuruFocus
Exagen secures $75 million credit facility with Perceptive Advisors By Investing.com - Investing.com South Africa
Exagen Secures $75 Million Credit Agreement - TipRanks
Exagen Enters up to $75 Million Credit Facility - marketscreener.com
Exagen secures $75 million credit facility with Perceptive Advisors - Investing.com India
Exagen Inc. Announces Senior Secured Credit Facility with Percep - GuruFocus
Exagen Inc. Announces Senior Secured Credit Facility with Perceptive Advisors - The Manila Times
Exagen stock soars to 52-week high, hits $6.23 amid robust gains - Investing.com Australia
Exagen Inc (XGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.60%
1.22%
자본화:
|
볼륨(24시간):